- Home
- SLDB vs NRIM Comparison
SLDB vs NRIM Comparison
Compare SLDB & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- NRIM
- Stock Information
- Founded
- SLDB 2013
- NRIM 1990
- Country
- SLDB United States
- NRIM United States
- Employees
- SLDB N/A
- NRIM N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- NRIM Savings Institutions
- Sector
- SLDB Health Care
- NRIM Finance
- Exchange
- SLDB Nasdaq
- NRIM Nasdaq
- Market Cap
- SLDB 529.4M
- NRIM 514.9M
- IPO Year
- SLDB 2018
- NRIM N/A
- Fundamental
- Price
- SLDB $6.11
- NRIM $86.30
- Analyst Decision
- SLDB Strong Buy
- NRIM
- Analyst Count
- SLDB 10
- NRIM 0
- Target Price
- SLDB $15.00
- NRIM N/A
- AVG Volume (30 Days)
- SLDB 1.4M
- NRIM 48.8K
- Earning Date
- SLDB 08-12-2025
- NRIM 07-23-2025
- Dividend Yield
- SLDB N/A
- NRIM 2.97%
- EPS Growth
- SLDB N/A
- NRIM 38.28
- EPS
- SLDB N/A
- NRIM 7.99
- Revenue
- SLDB N/A
- NRIM $175,041,000.00
- Revenue This Year
- SLDB N/A
- NRIM $11.28
- Revenue Next Year
- SLDB N/A
- NRIM $6.67
- P/E Ratio
- SLDB N/A
- NRIM $10.80
- Revenue Growth
- SLDB N/A
- NRIM 28.34
- 52 Week Low
- SLDB $2.41
- NRIM $63.64
- 52 Week High
- SLDB $10.37
- NRIM $100.21
- Technical
- Relative Strength Index (RSI)
- SLDB 49.25
- NRIM 46.70
- Support Level
- SLDB $5.87
- NRIM $81.19
- Resistance Level
- SLDB $6.81
- NRIM $88.85
- Average True Range (ATR)
- SLDB 0.46
- NRIM 1.89
- MACD
- SLDB -0.14
- NRIM 0.51
- Stochastic Oscillator
- SLDB 22.22
- NRIM 70.78
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.